Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05891119 · COMPLETED
Trial details
- NCT number
- NCT05891119
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-03
- Primary completion
- 2024-08-28
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.